2-[[2-(1,5-dimethyl-6-oxo-3-pyridinyl)-1-methylbenzimidazol-5-yl]methylamino]-3-methylbutanoic acid
C21H26N4O3 — CID 134248319
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[2-(1,5-dimethyl-6-oxo-3-pyridinyl)-1-methylbenzimidazol-5-yl]methylamino]-3-methylbutanoic acid
2-[[2-(1,5-dimethyl-6-oxo-3-pyridinyl)-1-methylbenzimidazol-5-yl]methylamino]-3-methylbutanoic acid (PubChem CID 134248319) has the molecular formula C21H26N4O3 and a molecular weight of 382.46 g/mol. Its IUPAC name is 2-[[2-(1,5-dimethyl-6-oxo-3-pyridinyl)-1-methylbenzimidazol-5-yl]methylamino]-3-methylbutanoic acid.
Molecular Properties
| Compound Name | 2-[[2-(1,5-dimethyl-6-oxo-3-pyridinyl)-1-methylbenzimidazol-5-yl]methylamino]-3-methylbutanoic acid |
|---|---|
| PubChem CID | 134248319 |
| Molecular Formula | C21H26N4O3 |
| Molecular Weight | 382.46 g/mol |
| Exact Mass | 382.20 |
| IUPAC Name | 2-[[2-(1,5-dimethyl-6-oxo-3-pyridinyl)-1-methylbenzimidazol-5-yl]methylamino]-3-methylbutanoic acid |
| SMILES | Cc1cc(-c2nc3cc(CNC(C(=O)O)C(C)C)ccc3n2C)cn(C)c1=O |
| InChI | InChI=1S/C21H26N4O3/c1-12(2)18(21(27)28)22-10-14-6-7-17-16(9-14)23-19(25(17)5)15-8-13(3)20(26)24(4)11-15/h6-9,11-12,18,22H,10H2,1-5H3,(H,27,28) |
| InChIKey | RGVBPFNFBLCTDP-UHFFFAOYSA-N |
| XLogP | 2.45 |
| TPSA | 89.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 382.46 |
| LogP ≤ 5 | 2.45 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134248319 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.